Last reviewed · How we verify
NCT04945447
Improving Medication Reviews to Polypharmacy Patients
NA trial testing Systematic pharmacist intervention in Polypharmacy Patients in 400 participants. Status unknown.
1 April 2024
Quick facts
| Lead sponsor | Aalborg University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 400 |
| Start date | 1 September 2021 |
| Primary completion | 1 April 2024 |
| Estimated completion | 1 January 2025 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Systematic pharmacist intervention
Conditions studied
- Polypharmacy Patients — all drugs for Polypharmacy Patients →
- Pharmacist Intervention — all drugs for Pharmacist Intervention →
Sponsor
Aalborg University
Who can join
18 and older, any sex, with Polypharmacy Patients or Pharmacist Intervention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Brief summary: The randomised controlled trial investigates the effect of a pharmacist intervention targeting polypharmacy patient at two levels medical clinics and patient level. The purpose is to gain more knowledge to patients and physicians about their medication and to see changes in the patient's medication and health-related quality of life.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
'You would rather not fill your body with pills'-patient perspectives on polypharmacy and medication reviews by pharmacists in general practice.
Als JG, Thomsen JL, Sørensen SS, Johnsen SP, et al · · 2025 · PMID 39803917 · DOI 10.1080/02813432.2025.2451660
Verify or expand the search:
- PubMed search for NCT04945447
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Polypharmacy Patients
Currently open trials in the same condition.
- NCT06110156 — Population Health Approach to Optimizing Medications in Older Adults · NA · active not recruiting
Other Aalborg University trials
Trials by the same sponsor.
- NCT07580989 — Network Effects of Left M1 rTMS: A TMS-EEG Study · NA · recruiting
- NCT07395882 — A New Model to Induce Itch and Inflammation · NA · not yet recruiting
- NCT07395869 — Off-set Analgesia Induced by Cold Temperature · NA · not yet recruiting
- NCT07266103 — Mechanistic Study of Personalized rTMS in Chronic Pain · NA · not yet recruiting
- NCT07373392 — Effects of LP-LDL® on Lipid Metabolism, Glycemic Control, Inflammatory Markers, and Cognitive Function in Individuals Wi · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04945447 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University
- Last refreshed: 9 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04945447.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing